VTVT Message Board Post 9880570 | vTv Therapeutics Inc.
home / stock / vtvt / vtvt message board
NataliedHill
(investorshub)
Posted on: Mar/06/2023 15:06:16
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171368420
Zero borrow and not optionable,low float target $4,insider
News, Short Squeeze, Breakout and More Instantly...
-
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...
-
CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING PR Newswire WESTON, Fla. , May 28, 2024 /PRNewswire/ -- Cantex Pharmaceuticals , Inc., a clinical stage pharmaceutical company focused on developi...